142 related articles for article (PubMed ID: 31466709)
1. The beta adrenergic receptor antagonist propranolol alters mitogenic and apoptotic signaling in late stage breast cancer.
Montoya A; Varela-Ramirez A; Dickerson E; Pasquier E; Torabi A; Aguilera R; Nahleh Z; Bryan B
Biomed J; 2019 Jun; 42(3):155-165. PubMed ID: 31466709
[TBL] [Abstract][Full Text] [Related]
2. Targeting of beta adrenergic receptors results in therapeutic efficacy against models of hemangioendothelioma and angiosarcoma.
Stiles JM; Amaya C; Rains S; Diaz D; Pham R; Battiste J; Modiano JF; Kokta V; Boucheron LE; Mitchell DC; Bryan BA
PLoS One; 2013; 8(3):e60021. PubMed ID: 23555867
[TBL] [Abstract][Full Text] [Related]
3. Blockade of beta-adrenergic receptors reduces cancer growth and enhances the response to anti-CTLA4 therapy by modulating the tumor microenvironment.
Fjæstad KY; Rømer AMA; Goitea V; Johansen AZ; Thorseth ML; Carretta M; Engelholm LH; Grøntved L; Junker N; Madsen DH
Oncogene; 2022 Feb; 41(9):1364-1375. PubMed ID: 35017664
[TBL] [Abstract][Full Text] [Related]
4. Propranolol and survival from breast cancer: a pooled analysis of European breast cancer cohorts.
Cardwell CR; Pottegård A; Vaes E; Garmo H; Murray LJ; Brown C; Vissers PA; O'Rorke M; Visvanathan K; Cronin-Fenton D; De Schutter H; Lambe M; Powe DG; van Herk-Sukel MP; Gavin A; Friis S; Sharp L; Bennett K
Breast Cancer Res; 2016 Dec; 18(1):119. PubMed ID: 27906047
[TBL] [Abstract][Full Text] [Related]
5. The antagonist of β-adrenergic receptor propranolol inhibits T cell lymphoma growth and enhances antitumor efficacy of cisplatin in vivo: A role of modulated apoptosis, glucose metabolism, pH regulation, and antitumor immune response.
Tiwari RK; Rawat SG; Kumar A
Int Immunopharmacol; 2023 Nov; 124(Pt A):110825. PubMed ID: 37619412
[TBL] [Abstract][Full Text] [Related]
6. Propranolol monotherapy in angiosarcoma - A window-of-opportunity study (PropAngio).
Embaby A; Heinhuis KM; IJzerman NS; Koenen AM; van der Kleij S; Hofland I; van Boven H; Sanders J; van der Graaf WTA; Haas RL; Huitema ADR; van Houdt WJ; Steeghs N
Eur J Cancer; 2024 May; 202():113974. PubMed ID: 38452721
[TBL] [Abstract][Full Text] [Related]
7. Chronic stress promotes gastric cancer progression and metastasis: an essential role for ADRB2.
Zhang X; Zhang Y; He Z; Yin K; Li B; Zhang L; Xu Z
Cell Death Dis; 2019 Oct; 10(11):788. PubMed ID: 31624248
[TBL] [Abstract][Full Text] [Related]
8. Beta-Blockers and Cancer: Where Are We?
Peixoto R; Pereira ML; Oliveira M
Pharmaceuticals (Basel); 2020 May; 13(6):. PubMed ID: 32466499
[TBL] [Abstract][Full Text] [Related]
9. Agonist Effects of Propranolol on Non-Tumor Human Breast Cells.
Gargiulo L; Rivero EM; di Siervi N; Buzzi ED; Buffone MG; Davio CA; Lüthy IA; Bruzzone A
Cells; 2020 Apr; 9(4):. PubMed ID: 32331276
[TBL] [Abstract][Full Text] [Related]
10. Propranolol suppresses gastric cancer cell growth by regulating proliferation and apoptosis.
Koh M; Takahashi T; Kurokawa Y; Kobayashi T; Saito T; Ishida T; Serada S; Fujimoto M; Naka T; Wada N; Yamashita K; Tanaka K; Miyazaki Y; Makino T; Nakajima K; Yamasaki M; Eguchi H; Doki Y
Gastric Cancer; 2021 Sep; 24(5):1037-1049. PubMed ID: 33782804
[TBL] [Abstract][Full Text] [Related]
11. Beta-blockade enhances anthracycline control of metastasis in triple-negative breast cancer.
Chang A; Botteri E; Gillis RD; Löfling L; Le CP; Ziegler AI; Chung NC; Rowe MC; Fabb SA; Hartley BJ; Nowell CJ; Kurozumi S; Gandini S; Munzone E; Montagna E; Eikelis N; Phillips SE; Honda C; Masuda K; Katayama A; Oyama T; Cole SW; Lambert GW; Walker AK; Sloan EK
Sci Transl Med; 2023 Apr; 15(693):eadf1147. PubMed ID: 37099632
[TBL] [Abstract][Full Text] [Related]
12. Preoperative β-Blockade with Propranolol Reduces Biomarkers of Metastasis in Breast Cancer: A Phase II Randomized Trial.
Hiller JG; Cole SW; Crone EM; Byrne DJ; Shackleford DM; Pang JB; Henderson MA; Nightingale SS; Ho KM; Myles PS; Fox S; Riedel B; Sloan EK
Clin Cancer Res; 2020 Apr; 26(8):1803-1811. PubMed ID: 31754048
[TBL] [Abstract][Full Text] [Related]
13. Beta-blocker adjunct therapy as a prospective anti-metastatic with cardio-oncologic regulation.
Nair SG; Benny S; Jose WM; Aneesh T P
Clin Exp Metastasis; 2024 Feb; 41(1):9-24. PubMed ID: 38177715
[TBL] [Abstract][Full Text] [Related]
14. Investigating Carvedilol's Repurposing for the Treatment of Non-Small Cell Lung Cancer via Aldehyde Dehydrogenase Activity Modulation in the Presence of β-Adrenergic Agonists.
Ikhmais BA; Hammad AM; Abusara OH; Hamadneh L; Abumansour H; Abdallah QM; Ibrahim AIM; Elsalem L; Awad M; Alshehada R
Curr Issues Mol Biol; 2023 Sep; 45(10):7996-8012. PubMed ID: 37886948
[TBL] [Abstract][Full Text] [Related]
15. Identification of propranolol and derivatives that are chemical inhibitors of phosphatidate phosphatase as potential broad-spectrum fungicides.
Zhao J; Chen Y; Ding Z; Zhou Y; Bi R; Qin Z; Yang L; Sun P; Sun Q; Chen G; Sun D; Jiang X; Zheng L; Chen XL; Wan H; Wang G; Li Q; Teng H; Li G
Plant Commun; 2024 Jan; 5(1):100679. PubMed ID: 37653727
[TBL] [Abstract][Full Text] [Related]
16. Challenges in Pharmacological Intervention in Perilipins (PLINs) to Modulate Lipid Droplet Dynamics in Obesity and Cancer.
Bombarda-Rocha V; Silva D; Badr-Eddine A; Nogueira P; Gonçalves J; Fresco P
Cancers (Basel); 2023 Aug; 15(15):. PubMed ID: 37568828
[TBL] [Abstract][Full Text] [Related]
17. ß-Adrenoreceptors in Human Cancers.
Kraboth Z; Kalman B
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835082
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer and neurotransmitters: emerging insights on mechanisms and therapeutic directions.
Jayachandran P; Battaglin F; Strelez C; Lenz A; Algaze S; Soni S; Lo JH; Yang Y; Millstein J; Zhang W; Shih JC; Lu J; Mumenthaler SM; Spicer D; Neman J; Roussos Torres ET; Lenz HJ
Oncogene; 2023 Feb; 42(9):627-637. PubMed ID: 36650218
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial Effects of Common Cardiovascular Medications: The Good, the Bad and the Mixed.
Bețiu AM; Noveanu L; Hâncu IM; Lascu A; Petrescu L; Maack C; Elmér E; Muntean DM
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362438
[TBL] [Abstract][Full Text] [Related]
20. Antidiabetics, Anthelmintics, Statins, and Beta-Blockers as Co-Adjuvant Drugs in Cancer Therapy.
Gales L; Forsea L; Mitrea D; Stefanica I; Stanculescu I; Mitrica R; Georgescu M; Trifanescu O; Anghel R; Serbanescu L
Medicina (Kaunas); 2022 Sep; 58(9):. PubMed ID: 36143915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
